Analysis Relief Therapeutics Holding AG (0QKQ)
5/31/2024
Analysis of Relief Therapeutics Holding AG (0QKQ)
Relief Therapeutics Holding AG (0QKQ) has been showing some interesting price movements recently. The stock closed at 1.70 on the most recent trading day, with a high of 1.72 and a low of 1.63.From a technical analysis perspective, the Relative Strength Index (RSI) is currently at 75.44, indicating that the stock may be overbought. The Moving Average Convergence Divergence (MACD) is positive, with the MACD line above the signal line, suggesting a bullish trend.
In terms of moving averages, the stock's Simple Moving Average (SMA) is at 1.29, the Exponential Moving Average (EMA) is at 1.32, and the Weighted Moving Average (WMA) is at 1.30.
Overall, the stock seems to be in a bullish phase based on the MACD indicator, but investors should be cautious of the high RSI value, which could indicate a potential reversal in the short term.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The company's fiscal year ends on September 30, 2023.
Moving on to stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock has a beta of 1.264, with a 52-week low of $164.08 and a high of $199.62.
Valuation metrics show a PEG ratio of 26.32, forward P/E of 26.32, and trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a market capitalization of $2.92 trillion. The stock is priced at a price-to-book ratio of 39.34 and a price-to-sales ratio of 7.65.
The stock price summary includes a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The stock has seen a 52-week change of 6.85%.
Lastly, dividends and splits information reveals a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company's dividend yield is 0.53% on a forward basis and 0.51% on a trailing basis. The last split date was on August 31, 2020, with a 4-for-1 split. The next dividend date is on May 16, 2024, with an ex-dividend date of May 10, 2024.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to FY 2023, the company had been experiencing a steady increase in revenue over the past three fiscal years.
- The highest revenue was recorded in FY 2022 at $394,328,000,000.
- The lowest revenue was recorded in FY 2020 at $274,515,000,000.
These trends indicate fluctuations in the company's revenue performance over the past four fiscal years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. The company has been steadily increasing its shareholders' equity from $90.5 billion in 2018 to $62.1 billion in 2023.
3. The liabilities have also been increasing, but at a slower pace compared to assets, indicating a healthy financial position.
4. The company has been investing more in non-current assets such as investments and advances, machinery, furniture, and equipment, which shows a focus on long-term growth.
5. The company has been managing its current assets well, with a good amount of cash, receivables, and short-term investments to cover its current liabilities.
6. Accumulated depreciation has been increasing, which might indicate aging assets or changes in depreciation methods.
7. The company has been taking on more long-term debt to finance its operations and investments.
8. Overall, the financial health of the company seems stable and growing, with a good balance between assets, liabilities, and equity.
Cash Flow 💶
This is a cash flow statement. Here are some key takeaways:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchases, long-term debt issuances and payments, and dividend payments.
5. Investing activities reflect acquisitions, capital expenditures, and the sale and purchase of investments.
6. The end cash position has also been fluctuating, with the highest value in 2020 and the lowest in 2022.
These insights provide a snapshot of the company's financial health and its management of cash flows over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates show an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:- The company is expected to have a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is expected to be 4.8%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of 11%.
- However, in the past 5 years, the company had a higher growth rate with a CAGR of 20.1%.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly lower growth rate in the short term compared to the past performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is $191.57, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
MACD of 0QKQ
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
